Latest Articles

Publication Date
Bayer launches phase III trial testing Mirena for uterine condition with no treatments - Indian Pharma Post

Bayer launches phase III trial testing Mirena for uterine condition with no treatments Indian Pharma Post

Published: Dec. 7, 2025, 6:02 a.m.
Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia - Bayer

Bayer starts Phase III study with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia Bayer

Published: Dec. 2, 2025, 7:30 a.m.
Mia X Grateful to Be Uterine Cancer Survivor After Surgery Mishap - SurvivorNet

Mia X Grateful to Be Uterine Cancer Survivor After Surgery Mishap SurvivorNet

Published: Dec. 2, 2025, 2:45 a.m.
‘ER’ Star Alex Kingston, 62, Says After Battling Uterine Cancer, She’s Become ‘Fearless’ - SurvivorNet

‘ER’ Star Alex Kingston, 62, Says After Battling Uterine Cancer, She’s Become ‘Fearless’ SurvivorNet

Published: Nov. 26, 2025, 3:57 p.m.
A Unique Case Series of Endometrial Vascular Dystrophy: Rising Incidence and Association With Uterine Pathologies - Cureus

A Unique Case Series of Endometrial Vascular Dystrophy: Rising Incidence and Association With Uterine Pathologies Cureus

Published: Nov. 25, 2025, 3:13 a.m.
Is sub-endometrial injection a superior method for the administration of intrauterine PRP?: a systematic review and meta-analysis - Reproductive Biology and Endocrinology

Is sub-endometrial injection a superior method for the administration of intrauterine PRP?: a systematic review and meta-analysis Reproductive Biology and Endocrinology

Published: Nov. 24, 2025, 11:46 a.m.
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech

Published: Nov. 13, 2025, 9 a.m.
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - facebook.com

Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …

Published: Nov. 10, 2025, 3:02 p.m.
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - Facebook

Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …

Published: Nov. 10, 2025, 3:02 p.m.
VDR uterine conditional knockout mice showed an endometrial fibrosis phenotype. (IMAGE) - EurekAlert!

VDR uterine conditional knockout mice showed an endometrial fibrosis phenotype. (IMAGE) EurekAlert!

Published: Nov. 8, 2025, 6:47 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!